18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma.
Costelloe CM, Macapinlac HA, Madewell JE, Fitzgerald NE, Mawlawi OR, Rohren EM, Raymond AK, Lewis VO, Anderson PM, Bassett RL Jr, Harrell RK, Marom EM.
Costelloe CM, et al. Among authors: rohren em.
J Nucl Med. 2009 Mar;50(3):340-7. doi: 10.2967/jnumed.108.058461.
J Nucl Med. 2009.
PMID: 19258257
Free article.